Observational Study
Copyright ©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 98932
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98932
Table 2 Treatment responses and follow-up information of adult patients with primary focal segmental glomerulosclerosis with kidney function loss at presentation who received steroid treatment, n = 81
Parameters
Results
Follow-up duration in weeks136.8 ± 20.6
Total steroid dose in mg4391.5 ± 1502.4
Duration of steroid treatment in weeks19.9 ± 14.4
Time to remission in weeks11.3 ± 6.7
Complete remission20/81 (24.6)
Partial remission9/81 (11.1)
No remission52/81 (64.1)
Spontaneous remission2 (2.4)